相似文献
1
Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain.
J Clin Microbiol. 2002 Dec;40(12):4741-3. doi: 10.1128/JCM.40.12.4741-4743.2002.
2
Clonal relatedness and resistance characteristics of OXA-24 and -58 producing carbapenem-resistant Acinetobacter baumannii isolates in Tehran, Iran.
J Appl Microbiol. 2019 Nov;127(5):1421-1429. doi: 10.1111/jam.14409. Epub 2019 Sep 10.
3
Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece.
Clin Microbiol Infect. 2006 Nov;12(11):1138-41. doi: 10.1111/j.1469-0691.2006.01537.x.
4
Prevalence of different carbapenemase genes among carbapenem-resistant blood isolates in Taiwan.
Antimicrob Resist Infect Control. 2018 Oct 11;7:123. doi: 10.1186/s13756-018-0410-5. eCollection 2018.
5
Phenotypic and genotypic characterization of carbapenem-resistant isolates from Egypt.
Antimicrob Resist Infect Control. 2019 Nov 20;8:185. doi: 10.1186/s13756-019-0611-6. eCollection 2019.
6
Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil.
J Clin Microbiol. 2003 Jul;41(7):3403-6. doi: 10.1128/JCM.41.7.3403-3406.2003.
7
OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
Indian J Med Microbiol. 2011 Jul-Sep;29(3):269-74. doi: 10.4103/0255-0857.83911.
8
A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages.
Microb Drug Resist. 2011 Dec;17(4):545-9. doi: 10.1089/mdr.2011.0089. Epub 2011 Aug 10.
9
Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia.
J Clin Microbiol. 2005 Sep;43(9):4826-9. doi: 10.1128/JCM.43.9.4826-4829.2005.
10
Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon.
Int J Infect Dis. 2016 Nov;52:29-36. doi: 10.1016/j.ijid.2016.09.017. Epub 2016 Sep 20.
引用本文的文献
1
Genomic Surveillance Uncovers a 10-Year Persistence of an OXA-24/40 Clone in a Tertiary Hospital in Northern Spain.
Int J Mol Sci. 2024 Feb 16;25(4):2333. doi: 10.3390/ijms25042333.
2
Multidrug-Resistant and Extensively Drug-Resistant Causing Nosocomial Meningitis in the Neurological Intensive Care Unit.
Microorganisms. 2023 Aug 6;11(8):2020. doi: 10.3390/microorganisms11082020.
3
The Role of Uniform Meropenem Usage in Clone Replacement.
Antibiotics (Basel). 2021 Jan 29;10(2):127. doi: 10.3390/antibiotics10020127.
4
OXA-207, a novel OXA-24 variant with reduced catalytic efficiency against carbapenems in Acinetobacter pittii from Spain.
Antimicrob Agents Chemother. 2014 Aug;58(8):4944-8. doi: 10.1128/AAC.02633-13. Epub 2014 Jun 2.
5
Complete genome analysis of three Acinetobacter baumannii clinical isolates in China for insight into the diversification of drug resistance elements.
PLoS One. 2013 Jun 24;8(6):e66584. doi: 10.1371/journal.pone.0066584. Print 2013.
6
"Stormy waters ahead": global emergence of carbapenemases.
Front Microbiol. 2013 Mar 14;4:48. doi: 10.3389/fmicb.2013.00048. eCollection 2013.
7
OXA-198, an acquired carbapenem-hydrolyzing class D beta-lactamase from Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2011 Oct;55(10):4828-33. doi: 10.1128/AAC.00522-11. Epub 2011 Jul 25.
8
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii.
Antimicrob Agents Chemother. 2009 Aug;53(8):3528-33. doi: 10.1128/AAC.00178-09. Epub 2009 Jun 1.
9
Acinetobacter baumannii: emergence of a successful pathogen.
Clin Microbiol Rev. 2008 Jul;21(3):538-82. doi: 10.1128/CMR.00058-07.
10
Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007.
J Clin Microbiol. 2008 Mar;46(3):1106-9. doi: 10.1128/JCM.01877-07. Epub 2008 Jan 23.
本文引用的文献
1
Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes.
J Antimicrob Chemother. 2002 May;49(5):837-40. doi: 10.1093/jac/dkf043.
2
IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK.
J Antimicrob Chemother. 2002 Jan;49(1):217-8. doi: 10.1093/jac/49.1.217.
3
Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species.
Clin Microbiol Infect. 2001 Feb;7(2):88-91. doi: 10.1046/j.1469-0691.2001.00204.x.
4
Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain.
J Med Microbiol. 2001 Jan;50(1):71-77. doi: 10.1099/0022-1317-50-1-71.
5
IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998.
Antimicrob Agents Chemother. 2001 Mar;45(3):710-4. doi: 10.1128/AAC.45.3.710-714.2001.
6
Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.
Antimicrob Agents Chemother. 2001 Feb;45(2):583-8. doi: 10.1128/AAC.45.2.583-588.2001.
7
Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii.
J Clin Microbiol. 2000 Nov;38(11):4086-95. doi: 10.1128/JCM.38.11.4086-4095.2000.
8
Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.
J Clin Microbiol. 2000 Sep;38(9):3299-305. doi: 10.1128/JCM.38.9.3299-3305.2000.
9
Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.
Clin Infect Dis. 2000 Jul;31(1):101-6. doi: 10.1086/313902. Epub 2000 Jul 17.
10
OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.
Antimicrob Agents Chemother. 2000 Jun;44(6):1556-61. doi: 10.1128/AAC.44.6.1556-1561.2000.
Zotero 插件